AGEN has been in the news 1227% more than usual
Dec 12, 2024, 7:30 PM
0.81%
What does AGEN do
Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.
AGEN has been in the news recently: Agenus has partnered with Tanner Pharma to offer expanded access to the investigational immunotherapies botensilimab and balstilimab for patients with advanced solid tumors, including colorectal cancer. This initiative is facilitated through a Named Patient Program, allowing patients with difficult-to-treat cancers to access these therapies.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.